Form 4 for ALZN Alzamend Neuro, Inc.
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001214659-22-003770 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-03-08 | 2022-03-04 | ALZN | AULT MILTON C III | 10% | J - Other | $1.50 | -57.0K | 14.94M | -0.4% | -$85.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-04 | J | D | 57,016 | $1.50 | 14,942,984 | I By Ault Life Sciences, Inc | — | — | (F2) Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc. |